PMH66 QUALITY OF LIFE AND PATIENT-REPORTED OUTCOMES- COMPARISONS OF INDIVIDUALS WITH SCHIZOPHRENIA TREATED WITH ORAL AND LONG-ACTING INJECTABLE FORMULATIONS OF OLANZAPINE
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74785-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)74785-9/fulltext
Title :
PMH66 QUALITY OF LIFE AND PATIENT-REPORTED OUTCOMES- COMPARISONS OF INDIVIDUALS WITH SCHIZOPHRENIA TREATED WITH ORAL AND LONG-ACTING INJECTABLE FORMULATIONS OF OLANZAPINE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74785-9&doi=10.1016/S1098-3015(10)74785-9
First page :
Section Title :
Open access? :
No
Section Order :
710